COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03213691
Brief Title: Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

First Submitted : July 10, 2017
First Submitted that Met QC Criteria : July 10, 2017
First Posted : July 11, 2017

Last Update Submitted that Met QC Criteria : December 31, 2020
Last Update Posted : January 5, 2021